NEW YORK (GenomeWeb News) – The bio-agricultural company Monsanto will use Cellectis' meganuclease genomic engineering technology under a new license agreement, Cellectis said today.

The Cellectis technology involves using "molecular scissors" that can locate a single site in the genome of a plant cell, allowing a range of precise genome modifications, such as gene stacking, gene knock-out, and modulation of gene function.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.